Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response (Q41441059)

30 September 2017

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response (English)

1 reference

30 September 2017

0 references

8

Christine Katlama

0 references

Guinevere Q Lee

object named as

Guinevere Q Lee

series ordinal

2

0 references

Diane Descamps

series ordinal

11

object named as

Diane Descamps

1 reference

PubMed ID

25755001

30 September 2017

Charlotte Charpentier

series ordinal

1

object named as

Charlotte Charpentier

1 reference

30 September 2017

9

Yazdan Yazdanpanah

1 reference

30 September 2017

7

Jean-Michel Molina

1 reference

30 September 2017

5

Alexandre Storto

1 reference

30 September 2017

4

Benoit Visseaux

1 reference

30 September 2017

3

Christophe Rodriguez

1 reference

30 September 2017

6

Catherine Fagard

1 reference

30 September 2017

P Richard Harrigan

10

1 reference

PubMed ID

25755001

30 September 2017

language of work or name

English

0 references

publication date

8 March 2015

1 reference

Journal of Antimicrobial Chemotherapy

30 September 2017

1 reference

30 September 2017

70

1 reference

30 September 2017

7

1 reference

30 September 2017

2090-2096

1 reference

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

30 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV048

21 January 2018

Identifiers

DOI

10.1093/JAC/DKV048

1 reference

30 September 2017

1 reference

PubMed ID

25755001